Table: Rohto - 6-MTH group results

Rohto Pharmaceutical

13/11/2024 06:31

Nov 13 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2024        Sep 30, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              139.08              127.87           320.00    
                   (+8.8 pct)          (+15.9 pct)      (+18.2 pct) 
  Operating           17.79               20.97            43.20    
                   (-15.1 pct)         (+28.9 pct)      (+7.9 pct)  
  Recurring           18.59               22.68            44.20    
                   (-18.0 pct)         (+26.2 pct)      (+4.2 pct)  
  Net                 12.92               16.59            32.20    
                   (-22.1 pct)         (+25.8 pct)      (+4.1 pct)  
  EPS               56.64 yen           72.74 yen       141.14 yen  
  EPS Diluted       56.47 yen           72.53 yen                   
  Ann Div                               27.00 yen        33.00 yen  
  -Q2 div           16.00 yen           12.00 yen                   
  -Q4 div                               15.00 yen        17.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T